ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

HOTH Hoth Therapeutics Inc

1.17
-0.04 (-3.31%)
시간외 거래
최종 업데이트: 07:04:56
15분 지연
기업명 주식 심볼 시장 주식 타입
Hoth Therapeutics Inc HOTH 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.04 -3.31% 1.17 07:04:56
개장가 저가 고가 종가 전일 종가
1.21 1.17 1.23 1.17 1.21
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00PRNUSHoth Therapeutics to Attend EF Hutton Annual Global..
28/03/202403:00PRNUSHoth Therapeutics Announces Exercise of Warrants for $4.2..
27/03/202421:27PRNUSHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai,..
19/03/202421:21PRNUSHoth Therapeutics Announces Positive Data In Completed Study..
29/02/202422:38PRNUSHoth Therapeutics Retains Venable LLP to Expand Its Patent..
26/02/202422:11PRNUSHoth Therapeutics Engages Altasciences to Perform Key Study..
14/02/202401:45PRNUSHoth Therapeutics to Attend BIO CEO and Investor Conference,..
18/01/202422:20PRNUSHoth Therapeutics Announces it Received FDA Approval to..
10/01/202405:03EDGAR2Form 8-K - Current report
09/01/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:21PRNUSHoth Therapeutics Announces Expansion of FDA Cleared..
05/12/202322:33PRNUSHoth Therapeutics Announces it Has Successfully Completed..
14/11/202322:37PRNUSHoth Therapeutics Announces Successful Completion of Pre-IND..
14/11/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202322:00PRNUSHoth Therapeutics to Present at NobleCon's 19th Annual..
05/10/202323:03PRNUSHoth Therapeutics Announces Merveille.ai Artificial..
05/10/202321:15EDGAR2Form 8-K - Current report
02/10/202321:33PRNUSFDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT,..
16/09/202305:15EDGAR2Form 8-K - Current report
16/09/202303:38PRNUSHoth Therapeutics Announces Closing of $2.89 Million..
15/09/202306:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/09/202302:43PRNUSHoth Therapeutics Announces $2.89 Million Registered Direct..
13/09/202321:16PRNUSHoth Therapeutics Announces Positive Results Killing Cancer..
11/09/202323:04PRNUSHoth Therapeutics Announces FDA Accepts Pre-Investigational..
06/09/202321:12PRNUSHoth Therapeutics Announces Positive Final Results from..
22/08/202306:10EDGAR2Form 8-K - Current report
22/08/202306:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/08/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202321:13PRNUSHoth Therapeutics Announces Positive Preclinical End Point..
25/07/202321:12PRNUSHoth Therapeutics Announces Major Milestone of First Patient..
19/07/202321:02PRNUSHoth Therapeutics Receives Protocol Approval for HT-001..
19/07/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/07/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/07/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/07/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/06/202321:12PRNUSHoth Therapeutics Announces IRB Approval for FDA Cleared..
06/06/202321:02PRNUSHoth Therapeutics Announces Positive Preclinical Results of..
12/05/202321:38PRNUSHoth Therapeutics and Algorithm Sciences Terminate Letter of..

최근 히스토리

Delayed Upgrade Clock